Conversion Chemoradiotherapy Combined with nab-paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline-Resectable or Unresectable Esophageal Squamous Cell Carcinoma: a Phase Ⅰ/Ⅱ Prospective Cohort Study
Preprint in Research Square (February 2024)